COMPLEMENTARY MEDICINES COMMUNICATION TO INDUSTRY

Document NumberTitleCategoriesDate UpdatedVersionUnitsLinkdoc_categories_hfilterdoc_tags_hfilter
CRO01-2025/26Core Business Escalation Procedure18/11/20251, , , , , , , , , , , Downloadcommunication-to-industrybiological-medicines-evaluation-and-research clinical-evaluations-management clinical-trials complementary-medicines inspectorate licencing medical-devices pharmaceutical-evaluation-management radiation-control regulatory-compliance section-21 veterinary-medicines
Communication to industry – SAHPRA Statement on Regulation of Category D Medicines02/06/20231Downloadcommunication-to-industrycomplementary-medicines
7.04Communication to industry – 7.04 Health Supplements Safety and Efficacy17/03/20221Downloadcommunication-to-industrycomplementary-medicines
Requests: Existing Category D (Complementary Medicines) Registration Applications (07 October 2021)17/02/20221Downloadcommunication-to-industrycomplementary-medicines
Communication to Stakeholders: Licensing of Complementary Medicines Manufacturers, Wholesalers, Distributors, Importers and Exporters26/02/20201Downloadcommunication-to-industrycomplementary-medicines
REQUESTS: Existing Category D (Complementary Medicines) Registration Applications – COMPLEMENTARY MEDICINES APPLICATIONS SUBMITTED FOR REGISTRATION27/10/20211Downloadcommunication-to-industrycomplementary-medicines
Review of detained product at a port of entry as a Category D medicine30/11/20211Downloadcommunication-to-industrycomplementary-medicines
Application for a certificate of free sale for Category D medicines (Complementary Medicines)24/11/20211Downloadcommunication-to-industrycomplementary-medicines
7.02updated – Roadmap and transitional process for the Regulation of complementary medicines08/12/20211Downloadcommunication-to-industrycomplementary-medicines